Arbor Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Arbor Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $1,445 - $1,639	-22 Reduced 0.6%	3,642 $252,000
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $26,364 - $31,219	385 Added 11.74%	3,664 $0
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $2,904 - $3,199	40 Added 1.23%	3,279 $252,000
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $199,133 - $238,779	3,239 New	3,239 $237,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Arbor Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arbor Investment Advisors, LLC with notifications on news.